Terug
54
Dagbereik
€ 23,70
€ 24,19
52-Weeksbereik
€ 9,03
€ 28,49
Volume
522.742
50D / 200D Gem.
€ 23,44
/
€ 19,06
Vorige Slotkoers
€ 23,32
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -22,0 | 0,4 |
| P/B | 6,7 | 2,9 |
| ROE % | -26,7 | 3,8 |
| Net Margin % | -76,6 | 3,9 |
| Rev Growth 5Y % | 41,2 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue grew 41,17% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -34,53M
PEG of 0,73 suggests growth is underpriced
Capital efficient — spends only 1,44% of revenue on capex
Groei
Revenue Growth (5Y)
41,17%
Revenue (1Y)38,87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-26,72%
ROIC-24,20%
Net Margin-76,56%
Op. Margin-87,34%
Veiligheid
Debt / Equity
0,07
Current Ratio5,52
Interest Coverage0,00
Waardering
P/E Ratio
-22,00
P/B Ratio6,65
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 38,87% | Revenue Growth (3Y) | 18,07% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 41,17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 105,97M | Net Income (TTM) | -81,13M |
| ROE | -26,72% | ROA | -23,41% |
| Gross Margin | 89,81% | Operating Margin | -87,34% |
| Net Margin | -76,56% | Free Cash Flow (TTM) | -34,53M |
| ROIC | -24,20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 5,52 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -22,00 | P/B Ratio | 6,65 |
| P/S Ratio | 16,84 | PEG Ratio | 0,73 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,78B | Enterprise Value | 1,76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 105,97M | 76,30M | 76,01M | 412,48M | 26,68M |
| Net Income | -81,13M | -122,70M | -118,67M | 124,34M | -211,84M |
| EPS (Diluted) | -1,08 | -1,62 | -1,72 | 1,90 | -4,61 |
| Gross Profit | 95,17M | 76,30M | -66,98M | 412,48M | 26,68M |
| Operating Income | -92,55M | -137,11M | -138,05M | 130,53M | -215,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 346,53M | 463,09M | 580,88M | 648,73M | 389,13M |
| Total Liabilities | 78,03M | 124,32M | 116,07M | 155,77M | 140,04M |
| Shareholders' Equity | 268,50M | 338,77M | 464,81M | 492,96M | 249,09M |
| Total Debt | 18,27M | 18,51M | 26,72M | 28,11M | 32,33M |
| Cash & Equivalents | 41,16M | 66,10M | 157,56M | 400,91M | 201,87M |
| Current Assets | 233,44M | 300,45M | 412,93M | 544,71M | 288,22M |
| Current Liabilities | 42,32M | 88,29M | 55,76M | 95,63M | 71,85M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#47 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026